Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Summary
The global Antiretroviral Drug Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019.
The Antiretroviral Drug Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Antiretroviral Drug Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.
The Key Manufacturers covered in this Report:-
- Gilead Sciences
- ViiV Healthcare
- Bristol-Myer Squibb
- AbbVie
- Boehringer-Ingelheim
- Johnson and Johnson
- Merck
- CIPLA
By the Product Type, the market is primarily segmented into:
- Multi-Class Drugs Combination
- NRTI
- NNRTI
- Protease Inhibitors
- Other
By Applications, the market is segmented into:
- Hospital
- Pharmaceutical Companies
- Other
The Report covers the following Regions:
- North America
- United States
- Canada
- Mexico
- Asia Pacific
- China
- Japan
- South Korea
- India
- Australia
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Central & South America
- Middle East & Africa
- Turkey
- GCC Countries
- Egypt
- South Africa
Objective of the Antiretroviral Drug Market Report:
- To assess the size of the market by value and volume
- Analyze the Antiretroviral Drug Market in terms of regions and major countries
- Highlight recent developments and trends in the market
- Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
- Determine share of the Antiretroviral Drug Market in terms of various segments such as by product type, application, and end-user
- Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
- Discuss major factors that impact growth of the Antiretroviral Drug Market
The Antiretroviral Drug Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Antiretroviral Drug Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders:
- Material suppliers/wholesalers
- Market Distributors/traders
- Regulatory bodies
- Research organizations, and consulting firms
- Commercial research & developments (R&D)
- Trade associations and industry bodies
- Importers and exporters
- End-use industries
Available Customizations:
Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Antiretroviral Drug Revenue
1.4 Market Analysis by Type
1.4.1 Global Antiretroviral Drug Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Multi-Class Drugs Combination
1.4.3 NRTI
1.4.4 NNRTI
1.4.5 Protease Inhibitors
1.4.6 Other
1.5 Market by Application
1.5.1 Global Antiretroviral Drug Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Pharmaceutical Companies
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Antiretroviral Drug Industry Impact
1.6.1 How the Covid-19 is Affecting the Antiretroviral Drug Industry
1.6.1.1 Antiretroviral Drug Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Antiretroviral Drug Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Antiretroviral Drug Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Antiretroviral Drug Market Perspective (2015-2026)
2.2 Antiretroviral Drug Growth Trends by Regions
2.2.1 Antiretroviral Drug Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Antiretroviral Drug Historic Market Share by Regions (2015-2020)
2.2.3 Antiretroviral Drug Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porters Five Forces Analysis
2.3.5 Antiretroviral Drug Market Growth Strategy
2.3.6 Primary Interviews with Key Antiretroviral Drug Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Antiretroviral Drug Players by Market Size
3.1.1 Global Top Antiretroviral Drug Players by Revenue (2015-2020)
3.1.2 Global Antiretroviral Drug Revenue Market Share by Players (2015-2020)
3.1.3 Global Antiretroviral Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Antiretroviral Drug Market Concentration Ratio
3.2.1 Global Antiretroviral Drug Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Antiretroviral Drug Revenue in 2019
3.3 Antiretroviral Drug Key Players Head office and Area Served
3.4 Key Players Antiretroviral Drug Product Solution and Service
3.5 Date of Enter into Antiretroviral Drug Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Antiretroviral Drug Historic Market Size by Type (2015-2020)
4.2 Global Antiretroviral Drug Forecasted Market Size by Type (2021-2026)
5 Antiretroviral Drug Breakdown Data by Application (2015-2026)
5.1 Global Antiretroviral Drug Market Size by Application (2015-2020)
5.2 Global Antiretroviral Drug Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Antiretroviral Drug Market Size (2015-2020)
6.2 Antiretroviral Drug Key Players in North America (2019-2020)
6.3 North America Antiretroviral Drug Market Size by Type (2015-2020)
6.4 North America Antiretroviral Drug Market Size by Application (2015-2020)
7 Europe
7.1 Europe Antiretroviral Drug Market Size (2015-2020)
7.2 Antiretroviral Drug Key Players in Europe (2019-2020)
7.3 Europe Antiretroviral Drug Market Size by Type (2015-2020)
7.4 Europe Antiretroviral Drug Market Size by Application (2015-2020)
8 China
8.1 China Antiretroviral Drug Market Size (2015-2020)
8.2 Antiretroviral Drug Key Players in China (2019-2020)
8.3 China Antiretroviral Drug Market Size by Type (2015-2020)
8.4 China Antiretroviral Drug Market Size by Application (2015-2020)
9 Japan
9.1 Japan Antiretroviral Drug Market Size (2015-2020)
9.2 Antiretroviral Drug Key Players in Japan (2019-2020)
9.3 Japan Antiretroviral Drug Market Size by Type (2015-2020)
9.4 Japan Antiretroviral Drug Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Antiretroviral Drug Market Size (2015-2020)
10.2 Antiretroviral Drug Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Antiretroviral Drug Market Size by Type (2015-2020)
10.4 Southeast Asia Antiretroviral Drug Market Size by Application (2015-2020)
11 India
11.1 India Antiretroviral Drug Market Size (2015-2020)
11.2 Antiretroviral Drug Key Players in India (2019-2020)
11.3 India Antiretroviral Drug Market Size by Type (2015-2020)
11.4 India Antiretroviral Drug Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Antiretroviral Drug Market Size (2015-2020)
12.2 Antiretroviral Drug Key Players in Central & South America (2019-2020)
12.3 Central & South America Antiretroviral Drug Market Size by Type (2015-2020)
12.4 Central & South America Antiretroviral Drug Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Gilead Sciences
13.1.1 Gilead Sciences Company Details
13.1.2 Gilead Sciences Business Overview and Its Total Revenue
13.1.3 Gilead Sciences Antiretroviral Drug Introduction
13.1.4 Gilead Sciences Revenue in Antiretroviral Drug Business (2015-2020))
13.1.5 Gilead Sciences Recent Development
13.2 ViiV Healthcare
13.2.1 ViiV Healthcare Company Details
13.2.2 ViiV Healthcare Business Overview and Its Total Revenue
13.2.3 ViiV Healthcare Antiretroviral Drug Introduction
13.2.4 ViiV Healthcare Revenue in Antiretroviral Drug Business (2015-2020)
13.2.5 ViiV Healthcare Recent Development
13.3 Bristol-Myer Squibb
13.3.1 Bristol-Myer Squibb Company Details
13.3.2 Bristol-Myer Squibb Business Overview and Its Total Revenue
13.3.3 Bristol-Myer Squibb Antiretroviral Drug Introduction
13.3.4 Bristol-Myer Squibb Revenue in Antiretroviral Drug Business (2015-2020)
13.3.5 Bristol-Myer Squibb Recent Development
13.4 AbbVie
13.4.1 AbbVie Company Details
13.4.2 AbbVie Business Overview and Its Total Revenue
13.4.3 AbbVie Antiretroviral Drug Introduction
13.4.4 AbbVie Revenue in Antiretroviral Drug Business (2015-2020)
13.4.5 AbbVie Recent Development
13.5 Boehringer-Ingelheim
13.5.1 Boehringer-Ingelheim Company Details
13.5.2 Boehringer-Ingelheim Business Overview and Its Total Revenue
13.5.3 Boehringer-Ingelheim Antiretroviral Drug Introduction
13.5.4 Boehringer-Ingelheim Revenue in Antiretroviral Drug Business (2015-2020)
13.5.5 Boehringer-Ingelheim Recent Development
13.6 Johnson and Johnson
13.6.1 Johnson and Johnson Company Details
13.6.2 Johnson and Johnson Business Overview and Its Total Revenue
13.6.3 Johnson and Johnson Antiretroviral Drug Introduction
13.6.4 Johnson and Johnson Revenue in Antiretroviral Drug Business (2015-2020)
13.6.5 Johnson and Johnson Recent Development
13.7 Merck
13.7.1 Merck Company Details
13.7.2 Merck Business Overview and Its Total Revenue
13.7.3 Merck Antiretroviral Drug Introduction
13.7.4 Merck Revenue in Antiretroviral Drug Business (2015-2020)
13.7.5 Merck Recent Development
13.8 CIPLA
13.8.1 CIPLA Company Details
13.8.2 CIPLA Business Overview and Its Total Revenue
13.8.3 CIPLA Antiretroviral Drug Introduction
13.8.4 CIPLA Revenue in Antiretroviral Drug Business (2015-2020)
13.8.5 CIPLA Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Table
List of Tables
Table 1. Antiretroviral Drug Key Market Segments
Table 2. Key Players Covered: Ranking by Antiretroviral Drug Revenue
Table 3. Ranking of Global Top Antiretroviral Drug Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Antiretroviral Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Multi-Class Drugs Combination
Table 6. Key Players of NRTI
Table 7. Key Players of NNRTI
Table 8. Key Players of Protease Inhibitors
Table 9. Key Players of Other
Table 10. COVID-19 Impact Global Market: (Four Antiretroviral Drug Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Antiretroviral Drug Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Antiretroviral Drug Players to Combat Covid-19 Impact
Table 15. Global Antiretroviral Drug Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Antiretroviral Drug Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Antiretroviral Drug Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Antiretroviral Drug Market Share by Regions (2015-2020)
Table 19. Global Antiretroviral Drug Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Antiretroviral Drug Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Antiretroviral Drug Market Growth Strategy
Table 25. Main Points Interviewed from Key Antiretroviral Drug Players
Table 26. Global Antiretroviral Drug Revenue by Players (2015-2020) (Million US$)
Table 27. Global Antiretroviral Drug Market Share by Players (2015-2020)
Table 28. Global Top Antiretroviral Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antiretroviral Drug as of 2019)
Table 29. Global Antiretroviral Drug by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Antiretroviral Drug Product Solution and Service
Table 32. Date of Enter into Antiretroviral Drug Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Antiretroviral Drug Market Size by Type (2015-2020) (Million US$)
Table 35. Global Antiretroviral Drug Market Size Share by Type (2015-2020)
Table 36. Global Antiretroviral Drug Revenue Market Share by Type (2021-2026)
Table 37. Global Antiretroviral Drug Market Size Share by Application (2015-2020)
Table 38. Global Antiretroviral Drug Market Size by Application (2015-2020) (Million US$)
Table 39. Global Antiretroviral Drug Market Size Share by Application (2021-2026)
Table 40. North America Key Players Antiretroviral Drug Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Antiretroviral Drug Market Share (2019-2020)
Table 42. North America Antiretroviral Drug Market Size by Type (2015-2020) (Million US$)
Table 43. North America Antiretroviral Drug Market Share by Type (2015-2020)
Table 44. North America Antiretroviral Drug Market Size by Application (2015-2020) (Million US$)
Table 45. North America Antiretroviral Drug Market Share by Application (2015-2020)
Table 46. Europe Key Players Antiretroviral Drug Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Antiretroviral Drug Market Share (2019-2020)
Table 48. Europe Antiretroviral Drug Market Size by Type (2015-2020) (Million US$)
Table 49. Europe Antiretroviral Drug Market Share by Type (2015-2020)
Table 50. Europe Antiretroviral Drug Market Size by Application (2015-2020) (Million US$)
Table 51. Europe Antiretroviral Drug Market Share by Application (2015-2020)
Table 52. China Key Players Antiretroviral Drug Revenue (2019-2020) (Million US$)
Table 53. China Key Players Antiretroviral Drug Market Share (2019-2020)
Table 54. China Antiretroviral Drug Market Size by Type (2015-2020) (Million US$)
Table 55. China Antiretroviral Drug Market Share by Type (2015-2020)
Table 56. China Antiretroviral Drug Market Size by Application (2015-2020) (Million US$)
Table 57. China Antiretroviral Drug Market Share by Application (2015-2020)
Table 58. Japan Key Players Antiretroviral Drug Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Antiretroviral Drug Market Share (2019-2020)
Table 60. Japan Antiretroviral Drug Market Size by Type (2015-2020) (Million US$)
Table 61. Japan Antiretroviral Drug Market Share by Type (2015-2020)
Table 62. Japan Antiretroviral Drug Market Size by Application (2015-2020) (Million US$)
Table 63. Japan Antiretroviral Drug Market Share by Application (2015-2020)
Table 64. Southeast Asia Key Players Antiretroviral Drug Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Antiretroviral Drug Market Share (2019-2020)
Table 66. Southeast Asia Antiretroviral Drug Market Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia Antiretroviral Drug Market Share by Type (2015-2020)
Table 68. Southeast Asia Antiretroviral Drug Market Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia Antiretroviral Drug Market Share by Application (2015-2020)
Table 70. India Key Players Antiretroviral Drug Revenue (2019-2020) (Million US$)
Table 71. India Key Players Antiretroviral Drug Market Share (2019-2020)
Table 72. India Antiretroviral Drug Market Size by Type (2015-2020) (Million US$)
Table 73. India Antiretroviral Drug Market Share by Type (2015-2020)
Table 74. India Antiretroviral Drug Market Size by Application (2015-2020) (Million US$)
Table 75. India Antiretroviral Drug Market Share by Application (2015-2020)
Table 76. Central & South America Key Players Antiretroviral Drug Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Antiretroviral Drug Market Share (2019-2020)
Table 78. Central & South America Antiretroviral Drug Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Antiretroviral Drug Market Share by Type (2015-2020)
Table 80. Central & South America Antiretroviral Drug Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Antiretroviral Drug Market Share by Application (2015-2020)
Table 82. Gilead Sciences Company Details
Table 83. Gilead Sciences Business Overview
Table 84. Gilead Sciences Product
Table 85. Gilead Sciences Revenue in Antiretroviral Drug Business (2015-2020) (Million US$)
Table 86. Gilead Sciences Recent Development
Table 87. ViiV Healthcare Company Details
Table 88. ViiV Healthcare Business Overview
Table 89. ViiV Healthcare Product
Table 90. ViiV Healthcare Revenue in Antiretroviral Drug Business (2015-2020) (Million US$)
Table 91. ViiV Healthcare Recent Development
Table 92. Bristol-Myer Squibb Company Details
Table 93. Bristol-Myer Squibb Business Overview
Table 94. Bristol-Myer Squibb Product
Table 95. Bristol-Myer Squibb Revenue in Antiretroviral Drug Business (2015-2020) (Million US$)
Table 96. Bristol-Myer Squibb Recent Development
Table 97. AbbVie Company Details
Table 98. AbbVie Business Overview
Table 99. AbbVie Product
Table 100. AbbVie Revenue in Antiretroviral Drug Business (2015-2020) (Million US$)
Table 101. AbbVie Recent Development
Table 102. Boehringer-Ingelheim Company Details
Table 103. Boehringer-Ingelheim Business Overview
Table 104. Boehringer-Ingelheim Product
Table 105. Boehringer-Ingelheim Revenue in Antiretroviral Drug Business (2015-2020) (Million US$)
Table 106. Boehringer-Ingelheim Recent Development
Table 107. Johnson and Johnson Company Details
Table 108. Johnson and Johnson Business Overview
Table 109. Johnson and Johnson Product
Table 110. Johnson and Johnson Revenue in Antiretroviral Drug Business (2015-2020) (Million US$)
Table 111. Johnson and Johnson Recent Development
Table 112. Merck Company Details
Table 113. Merck Business Overview
Table 114. Merck Product
Table 115. Merck Revenue in Antiretroviral Drug Business (2015-2020) (Million US$)
Table 116. Merck Recent Development
Table 117. CIPLA Business Overview
Table 118. CIPLA Product
Table 119. CIPLA Company Details
Table 120. CIPLA Revenue in Antiretroviral Drug Business (2015-2020) (Million US$)
Table 121. CIPLA Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antiretroviral Drug Market Share by Type: 2020 VS 2026
Figure 2. Multi-Class Drugs Combination Features
Figure 3. NRTI Features
Figure 4. NNRTI Features
Figure 5. Protease Inhibitors Features
Figure 6. Other Features
Figure 7. Global Antiretroviral Drug Market Share by Application: 2020 VS 2026
Figure 8. Hospital Case Studies
Figure 9. Pharmaceutical Companies Case Studies
Figure 10. Other Case Studies
Figure 11. Antiretroviral Drug Report Years Considered
Figure 12. Global Antiretroviral Drug Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Antiretroviral Drug Market Share by Regions: 2020 VS 2026
Figure 14. Global Antiretroviral Drug Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Antiretroviral Drug Market Share by Players in 2019
Figure 17. Global Top Antiretroviral Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antiretroviral Drug as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Antiretroviral Drug Revenue in 2019
Figure 19. North America Antiretroviral Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Antiretroviral Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Antiretroviral Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Antiretroviral Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Antiretroviral Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Antiretroviral Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Antiretroviral Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Gilead Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Gilead Sciences Revenue Growth Rate in Antiretroviral Drug Business (2015-2020)
Figure 28. ViiV Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. ViiV Healthcare Revenue Growth Rate in Antiretroviral Drug Business (2015-2020)
Figure 30. Bristol-Myer Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Bristol-Myer Squibb Revenue Growth Rate in Antiretroviral Drug Business (2015-2020)
Figure 32. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. AbbVie Revenue Growth Rate in Antiretroviral Drug Business (2015-2020)
Figure 34. Boehringer-Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Boehringer-Ingelheim Revenue Growth Rate in Antiretroviral Drug Business (2015-2020)
Figure 36. Johnson and Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Johnson and Johnson Revenue Growth Rate in Antiretroviral Drug Business (2015-2020)
Figure 38. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Merck Revenue Growth Rate in Antiretroviral Drug Business (2015-2020)
Figure 40. CIPLA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. CIPLA Revenue Growth Rate in Antiretroviral Drug Business (2015-2020)
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Figure 44. Key Executives Interviewed
